Mirae Asset Global Etfs Holdings Ltd. Cassava Sciences Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 21,151 shares of SAVA stock, worth $572,346. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,151Holding current value
$572,346% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SAVA
# of Institutions
189Shares Held
13.5MCall Options Held
1.38MPut Options Held
2.26M-
Black Rock Inc. New York, NY3.22MShares$87.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.68MShares$72.6 Million0.0% of portfolio
-
State Street Corp Boston, MA1.18MShares$31.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$27.3 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA691KShares$18.7 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $1.09B
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...